Contact Us    |      Join    |

"The Voice of Oncology in Massachusetts"

Take Action: House Votes to Extend Telehealth Flexibilities Through 2024

August 04, 2022 1:55 PM | Katy Monaco (Administrator)

On July 27, 2022, the House of Representatives passed the Advancing Telehealth Beyond COVID–19 Act of 2021 (H.R.4040). The bill, which was introduced by Representatives Liz Cheney (R-WY-AL) and Debbie Dingell (D-MI-12), would extend telehealth flexibilities for two years, through the end of 2024.

Specifically, the legislation would:  • remove geographic and originating site restrictions • expand providers who can offer telehealth service—including physician assistants, nurse practitioners, and others  • allow Medicare reimbursement of telehealth services provided by physicians and practitioners working for Federally Qualified Health Centers (FQHCs) and Rural Health Centers (RHCs)  • allow audio-only telehealth services  • expand access to telehealth services for the recertification of hospice care eligibility during an emergency period 

The Association for Clinical Oncology (ASCO) was pleased to see that several provisions in the bill align with provisions in the Permanency for Audio-Only Telehealth Act and the CONNECT for Health Act and Telehealth Modernization Act—two bills that ASCO endorsed and advocated for on Capitol Hill. Those provisions include removing geographic and originating site restrictions, expanding reimbursement for telehealth services provided by physicians working for FQHCs and RHCs, and expanding access to audio-only telehealth services.

The bill has moved to the Senate, where its path forward is unclear. While there is broad support for extending telehealth flexibilities beyond the COVID-19 Public Health Table of Contents Encourage your members to join the State Society Network Emergency, a full agenda and limited legislative days are creating obstacles.

Take action now via the ASCO ACT Network. 


ADDRESS

860 Winter Street, Waltham, MA, 02451

CONTACT US

tel: 781.434.7329

msco@mms.org

Massachusetts Society of Clinical Oncologists ©2024

Powered by Wild Apricot Membership Software